US20020049490A1 - Single-piece endoprosthesis with high expansion ratios - Google Patents
Single-piece endoprosthesis with high expansion ratios Download PDFInfo
- Publication number
- US20020049490A1 US20020049490A1 US09/837,353 US83735301A US2002049490A1 US 20020049490 A1 US20020049490 A1 US 20020049490A1 US 83735301 A US83735301 A US 83735301A US 2002049490 A1 US2002049490 A1 US 2002049490A1
- Authority
- US
- United States
- Prior art keywords
- endoprosthesis
- prosthesis
- longitudinal members
- beams
- cylindrical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000005452 bending Methods 0.000 claims description 13
- 230000006835 compression Effects 0.000 description 17
- 238000007906 compression Methods 0.000 description 17
- 230000008901 benefit Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 230000002792 vascular Effects 0.000 description 9
- 206010002329 Aneurysm Diseases 0.000 description 8
- 229910001000 nickel titanium Inorganic materials 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 5
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 4
- 229910045601 alloy Inorganic materials 0.000 description 4
- 239000000956 alloy Substances 0.000 description 4
- 238000000137 annealing Methods 0.000 description 3
- 210000000702 aorta abdominal Anatomy 0.000 description 3
- 210000001105 femoral artery Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009760 electrical discharge machining Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 238000001259 photo etching Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91516—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
Definitions
- This invention relates to medical devices for the treatment of vascular diseases generally referred to as endoluminal prostheses.
- endoluminal prostheses A variety of such devices are available for a broad range of treatment modalities. Examples of such devices are “vascular grafts” and “stents.”
- Vascular grafts are typically used to treat weakened areas of vessels known as aneurysms.
- Stents are typically used to prop open a narrowed or stenosed vessel.
- Stents and grafts may be delivered intraluminally through a narrow incision or a puncture in the patient's skin.
- the device may be mounted on a delivery catheter and inserted into a corporeal lumen through the skin. The device and catheter are then advanced through the various lumens to the site to be treated.
- stents and grafts are generally collapsible for delivery and expansible for treatment.
- Vascular grafts are primarily composed of an artificial lumen which isolates the natural lumen from the flow of bodily fluids, such as blood. Grafts may incorporate attachment devices to secure the graft into the natural lumen and keep the graft expanded.
- Stents are typically formed of metallic wire or bars configured in a cylinder.
- Prior art stents have generally taught that the resulting thickness of the cylinder should be kept small to provide as large of an open lumen as possible. They have also taught the use of wide bar elements to compress plaque or tissue and hold it against the lumen wall. These stents expand by configuring the elements of the cylindrical structure such that they bend from a generally longitudinal orientation while compressed to a more circumferential orientation while expanded. These bending elements are then connected by elements which typically lie and remain in a circumferential orientation. This configuration limits the compressibility of the prior art stents because elements in a circumferential orientation cannot be tightly packed and thin elements in a longitudinal orientation tend to overlap while compressed.
- At least one prior art device has incorporated the benefits of a cylindrical structure composed of flat wires. This device is described in U.S. Pat. No. 5,993,482 (Chuter) as a Flat-Wire Stent. The teachings of that patent are hereby incorporated by reference.
- the Chuter flat-wire stent teaches a stent comprised of flat-wires which results in a relatively thick-walled structure. This approach has proven to have many advantages.
- the Chuter flat-wire stent exhibits a greater expansion ratio than other prosthesis. This is due in part to superior packability when compressed. Other advantages include a reduction in stress concentrations while expanded and the minimizing of foreshortening during expansion.
- the present invention relates to an improved endoluminal prosthesis.
- This prosthesis may function as a stent or as a means to secure an endoluminal graft in a corporeal lumen such as an artery.
- Stents typically are used to ensure the patency of diseased corporeal lumens by resisting collapse and occlusion.
- Endoluminal grafts typically are used to isolate diseased corporeal lumens from the flow of bodily fluids.
- the prosthesis incorporating the present invention is configured as a series of intermittently merging curved beams (e.g. leaf springs) formed into a cylinder.
- This cylindrical structure is capable of being compressed into a small diameter and expanded into a large diameter.
- the beams have a cross-section which is greater in the radial direction (thickness) than in the circumferential direction (width).
- the beams of the present invention are also generally continuously curved to reduce or minimize stress concentrations in the structure. The beams straighten during compression until they are nearly straight.
- the thickness of the beams prevents overlap.
- the curved beams straighten out, come together and generally lie flat in close proximity to each other.
- the beams resist overlap because the thickness of each beam requires substantial radial displacement to move over or under the adjacent beam.
- the compression of the prosthesis may be maximized by configuring the beams to fit together tightly in a collapsed condition.
- the thickness of the beams and the configuration of the beams increase the strength of the prosthesis and reduce or minimize stress concentrations.
- Thicker beams provide for more material in the radial direction to prevent radial collapse.
- the curved configuration of the beams spreads the bending due to expansion throughout the entire length of the beam. This prevents one area of the beam from generating most of the bending and withstanding resultant stress concentrations.
- further improvements distribute stresses throughout the beams more evenly.
- the extreme ends of adjacent beams may be connected by a loop or eyelet connector.
- the stresses from bending due to compression of the prosthesis concentrate in the loop portion of the connector until the lower portion of the connector just adjacent to the loop portion closes on itself, bringing the adjacent beams into contact. Further compression after that point concentrates stresses in the beam below the loop.
- a similar result can be achieved by configuring the beams to form a significant area of contact adjacent other types of connectors prior to full compression of the prosthesis.
- the present invention is a single integrated structure without welds or fasteners. This may be accomplished by removing almond-shaped cells from a thick-walled cylinder. This eliminates the need to construct the prosthesis from individual pieces and possible weak points created by fasteners or joining.
- the prosthesis may have curved beams which are only merged to adjacent beams at their end points. This creates a single repetitive pattern around the circumference of the cylinder, with each beam merged to opposite adjacent beams at opposite end points.
- This embodiment may be viewed as the simplest structure to include the invention described herein. It includes alternating half-cells divided by curved beams. This embodiment is not necessarily short, as the beams may be of any length. However, it may be viewed as the shortest configuration for any given cell size.
- the prosthesis may have curved beams like leaf springs which are repeatedly merged to alternating adjacent beams throughout their length.
- This second embodiment may also be viewed as the single repetitive pattern of the first embodiment repeated throughout the length of the prosthesis.
- a prosthesis may be comprised of two or more of the single pattern prosthesis connected end to end. Instead of actually connecting the prosthesis, they may be formed as a single structure. Thereby, the beams could be viewed as continuous throughout the length of the prosthesis. The beams would then have many curved portions which bring them in connection with alternating adjacent beams at merge sections.
- the prosthesis may also embody these curved beams forming individual cylindrical elements and connected together by separate elements.
- a variety of prosthesis may be formed by connecting different cylindrical elements together with different connecting elements.
- One configuration includes cylindrical elements having curved beams which are only merged to adjacent beams at their end points connected to cylindrical elements having curved beams which are repeatedly merged to alternating adjacent beams throughout their length. This provides a prosthesis having varying strength and flexibility throughout its length.
- the prosthesis may be intraluminally inserted and delivered within a corporeal lumen. Once delivered to the site to be treated, the prosthesis may be expanded and imbedded into the interior of the lumen.
- Various methods for intraluminally expanding prostheses are well-known in the art. Expansion due to spring forces is particularly suited for this invention.
- the super-elastic properties of Nickel-Titanium alloys allow a great amount of expansion and compression of structures without permanent deformation. Thus a prosthesis made of such material may be compressed into a very small configuration, and will spring back into a preset form when released.
- Other known methods of expansion include balloon expansion, and expansion due to the highly elastic properties of certain alloys.
- the present invention may also be balloon expandable.
- an angioplasty-type dilation catheter is inserted through a compressed or not-fully expanded prosthesis until the balloon portion of the catheter is longitudinally aligned within the prosthesis.
- the balloon is then expanded forcing the prosthesis radially outwardly.
- the prosthesis remains in the expanded condition, and the strength of the prosthesis resists radial collapse.
- the prosthesis can expand and resist re-collapse of a previously collapsed or stenosed corporeal lumen.
- the prosthesis can maintain the graft open and secure the graft to the vessel.
- Additional preferred embodiments of the present invention may provide benefits for high-expansion ratios. That is, the prosthesis may be configured to readily withstand high degrees of expansion and compression.
- Prostheses having loop or eyelet connectors according to this invention may also include beams of different lengths. Alternating pairs of beams having longer lengths and shorter lengths provide a more controlled expansion. This configuration also permits the eyelets of the shorter length beams to nestle below the eyelets of the longer length beams upon compression.
- a further feature aiding the expansion of the prosthesis includes varying the widths of the individual beams. For example, configuring beams having longer lengths with greater widths will improve the prosthesis ability to accomplish high expansion. Furthermore, varying the width along the length of the beam may also improve the expansion and compression abilities of prosthesis.
- prosthesis may be beneficial when the prosthesis is used in combination with a graft.
- the ends of prosthesis which are to be configured within a graft may include a flattened bulbous tail. Such an extension of the prosthesis prevents wear on the fabric of the graft. Eyelets on the ends of the prosthesis may also be used for stitching the prosthesis together with the graft. Eyelets provide a good anchoring point for such stitching.
- Various combinations of connected prosthesis according to the present invention may be used within grafts.
- FIG. 1 is a perspective view of a first embodiment of the prosthesis in an expanded condition.
- FIG. 2 is a perspective view of the first embodiment of the prosthesis in a compressed condition.
- FIG. 3 is a cross-sectional view of the first embodiment of the prosthesis in an expanded condition.
- FIG. 4 is a cross-sectional view of the first embodiment of the prosthesis in a compressed condition.
- FIG. 5 is a perspective view of a second embodiment of the prosthesis.
- FIG. 6 is a side view of a third embodiment of the prosthesis.
- FIG. 7 is a top view of a portion of a flat pattern for the prosthesis.
- FIG. 8 is a side view of a fourth embodiment of the prosthesis.
- FIG. 9 is a side view of a vascular graft secured in a corporeal lumen by a prosthesis.
- FIG. 10 is a side view of a prosthesis embedded in a corporeal lumen.
- FIG. 11 is a perspective view of a thick-walled cylindrical tube with cells designed therein.
- FIG. 12 is a flat pattern view of a portion of a prosthesis embodying variable thickness beams.
- FIG. 13 is a flat pattern view of a portion of a prosthesis including alternative embodiments of variable thickness beams.
- FIG. 14 is a flat pattern view of a portion of a prosthesis including additional alternative embodiments of variable thickness beams.
- FIG. 15 is a flat pattern view of a portion of a prosthesis including additional alternative embodiments having varying flexibility.
- FIGS. 16 a and 16 b are side views of a first alternative embodiment of the beam ends and connector.
- FIGS. 17 a and 17 b are side views of a second alternative embodiment of the beam ends and connector.
- FIG. 18 is a flat pattern view of a first embodiment of a prosthesis having the alternative beam end connectors shown in FIGS. 16 a and 16 b.
- FIG. 19 is a flat pattern view of a second embodiment of a prosthesis having the alternative beam end connectors shown in FIGS. 16 a and 16 b.
- FIG. 20 is a flat pattern view of the prosthesis of FIG. 19 in a collapsed state.
- FIG. 21 is a flat pattern view of a prosthesis from within a vascular graft.
- the present invention relates to an endoluminal prosthesis. More particularly, the invention is an expandable and compressible prosthesis for repairing corporeal lumens.
- the prosthesis may be formed from a metallic cylinder by removal of cells.
- the result of removing cells 20 from the metallic cylinder 22 is a prosthesis 24 having a series of curved beams 26 and merge sections 28 . It is to be recognized that the prosthesis 24 shown in FIG. 2 can be compressed, where desired, to a smaller diameter such that the cells 20 are essentially defined by slits (not shown).
- the beams 26 are generally longitudinal members circumferentially spaced about the prosthesis 24 .
- the ends of these beams 26 merge with the ends of circumferentially adjacent beams to form the merge sections 28 only at the ends of the prosthesis.
- the ends of each beam 26 merge with one adjacent beam on the forward end 30 and the opposite adjacent beam on the rear end 32 .
- a full cell 25 is identified in FIG. 1).
- the beams 26 each include at least two curved segments 34 of opposite orientations and an inflection point 36 near the mid-point of the beams.
- the merge sections 28 include either the forward ends 30 or rear ends 32 of two such beams 26 as well as the ends of the prosthesis. These merge sections 28 are also circumferentially spaced about the prosthesis 24 , preferably equidistantly.
- the single pattern as depicted in FIG. 5 may be extended to build longer prostheses 24 . This may be done by extending the length of each beam 26 with additional curved segments 34 and forming additional merge sections 28 . This forms the prosthesis 24 as depicted in FIGS. 1 and 2.
- multiple single patterns may be connected with a separate connector element 58 .
- the connector elements 58 may have various configurations and be distributed throughout the prosthesis 24 in a variety of arrangements.
- Such a prosthesis 24 having “S”-shaped connector elements at each merge section is depicted in FIG. 6.
- Other embodiments may have connectors with other shapes only at every second or third merge section. Such embodiments may have advantages in providing longitudinal flexibility to the prosthesis 24 .
- the beams 26 may extend beyond the first merge sections 28 to form additional merge sections 28 .
- This configuration may also be viewed as the merge sections 28 connected end-to-end with opposite facing merge sections 28 . This may provide for a prosthesis 24 of greater lengths.
- the continuous beams 26 of this embodiment merge with adjacent beams 26 repeatedly and alternately throughout their length.
- the continuous beams are comprised of multiple curved segments 34 .
- the merge sections 28 may also contain flat segments (not shown).
- the prosthesis 24 is preferably formed from a thick-walled cylinder 22 .
- the difference between the external radius of the cylinder and the internal radius of the cylinder defines a radial thickness 40 .
- the cells 20 of the prosthesis 24 are removed such that the remaining beams 26 have a width (measured circumferentially) 42 that is less than the radial thickness 40 .
- a typical design might have dimensions of 0.007′′ circumferential width 42 and 0.014′′ radial thickness 40 . This defines a deep cross-section for the beams 26 .
- the radial thickness 40 of the beams 26 needs to be substantially greater than the circumferential width 42 .
- the radial thickness 40 will be at least one and one-third (11 ⁇ 3) times the circumferential width 42 .
- each beam 26 is continuously curved, alternating between curves 56 of opposite orientations throughout its length. In this ideal configuration, the beams 26 form inflection points 36 between the opposite facing curves 56 .
- Each curve 56 in each beam 26 is defined by two radii, an internal radius 64 and an external radius 66 . The difference between these radii define the circumferential width 42 of the beam 26 .
- the continuously curved configuration of beams 26 disposed longitudinally along a cylinder provides some of the unique properties of this invention. As the cylinder is expanded from a partially compressed configuration 50 , the radii of each curve 56 within each beam 26 becomes smaller as the beams spread apart. Since the beams 26 are ideally continuously curved, the bending is spread throughout the entire length of the beam 26 . This spreads the resultant stresses throughout the beam 26 and reduced or minimizes stress concentrations.
- the use of deep cross-sections has significant advantages for collapsing the prosthesis 24 in preparation of intraluminal delivery.
- the deep cross-section allows for significant compression without incidental overlapping of the beams 26 .
- the large radial thickness 40 of the beams 26 prevents one beam from extending over the top of another.
- FIGS. 1 and 3 there are also advantages to the use of deep cross-sections in expansion of the prosthesis 24 .
- longitudinally-oriented members of the collapsed prosthesis tend to bend circumferentially.
- the relatively narrow width of the beams 26 of the present prosthesis 24 permits circumferential bending without inducing high stress concentrations.
- the large overall cross-sectional area of the beams 26 prevents recompression of the prosthesis 24 .
- the configuration of the curved segments 34 spreads the stresses induced by expansion across the entire length of the beams 26 , also reducing stress concentrations.
- the prosthesis is self-expandable.
- the prosthesis may be expanded by balloon.
- FIGS. 1 and 3 and FIGS. 2 and 4 depict two separate configurations of the prosthesis 24 .
- the prosthesis 24 of the present invention has an expanded configuration 44 while deployed in the lumen as depicted in FIGS. 1 and 3. This configuration has a large inner diameter which allows maximum patency of the lumen 46 to be treated.
- the prosthesis 24 of the present invention also has a second partial compressed configuration 50 as depicted in FIGS. 2 and 4. This configuration is beneficial to the intraluminal delivery of the device which is facilitated by a smaller external diameter.
- the prosthesis 24 will be constrained in the compressed configuration 50 within a catheter.
- This catheter may then be inserted into a small diameter lumen 46 such as the femoral artery.
- a small diameter lumen 46 such as the femoral artery.
- the entire system of catheter and prosthesis 24 must have as small a diameter as possible. Small diameters also facilitate the navigation of the prosthesis 24 and catheter through arduous vasculature.
- the catheter and prosthesis 24 may be advanced through the corporeal lumens, possibly to larger arteries for treatment.
- the prosthesis 24 may then be released from the catheter. Spring forces within the compressed prosthesis of a self-expanding version will force the prosthesis from the partially compressed configuration 50 into the expanded configuration 44 .
- the spring forces may be great enough to expand the lumen of the diseased vessel as the prosthesis 24 expands. These forces will also be great enough to impinge the beams 26 into the tissues of the vessel. This impinging secures the prosthesis 24 and possibly an associated graft 52 into place.
- FIG. 8 Another embodiment of the prosthesis 24 , depicted in FIG. 8, has a conical rather than cylindrical shape while in the expanded configuration 44 .
- the prosthesis 24 has a cylindrical shape in the compressed configuration 50 .
- a broader end 60 of the prosthesis 24 expands more than a narrower end 62 .
- This conical embodiment of the prosthesis 24 is useful in similarly shaped lumens and various configurations of grafts.
- the broader end 60 may include cells 20 that are longer and wider in the expanded configuration 44 , than those at the narrower end 62 .
- the prosthesis 24 of the current invention may be used in a variety of procedures, two of which are depicted in FIGS. 9 and 10.
- one or more prostheses embodying the present invention may be used in the treatment of aneurysms.
- An aneurysm is a weakening of the vessel wall of a vein or artery, causing a sack to form in the lumen 46 or possibly rupture.
- a known treatment for aneurysms is the intraluminal delivery and implantation of a vascular graft 52 .
- Such a graft 52 bypasses the sack formed by the aneurysm and isolates the weakened tissues from the blood flow.
- the graft 52 must have leak-proof fixation to the healthy vascular tissue on either side of the aneurysm.
- the prosthesis 24 described herein may provide that fixation at one or more ends of the graft 52 .
- the prosthesis 24 may also extend throughout the length of the graft 52 . When expanded the prosthesis 24 may compress the flexible graft material 52 against the arterial wall.
- the prosthesis 24 extends further from the aneurysm than the graft 52 so that parts of the prosthesis 24 are imbedded in healthy tissue. This configuration maintains the patency of the artificial lumen of the graft 52 as well as securing the graft in place by forcing the end of the graft against the wall of the lumen 46 .
- the prosthesis 24 also ensures a leak-proof seal.
- a prosthesis 24 embodying the present invention may be used to treat a stenosis or collapse of the lumen 46 .
- Stenosis is often caused by the gradual occlusion of veins or arteries through the build-up of plaque.
- a single prosthesis 24 is inserted into the diseased vessel while mounted within a catheter.
- the prosthesis 24 may be expanded.
- the spring forces of the prosthesis are preferably sufficient to expand the narrowed vessel.
- the prosthesis 24 is thereby forced into the tissues of the lumen 46 to secure the prosthesis 24 in place.
- the structure of the prosthesis 24 resists collapse after expansion.
- the prosthesis 24 may be manufactured in the compressed configuration 50 as in FIG. 2, or in the expanded configuration 44 as in FIG. 1 or in any configuration in between.
- the manufacturing procedure requires the removal of cells 20 from a thick-walled cylinder 22 . This may be accomplished with several known manufacturing methods such as laser cutting, chemical etching, photo-etching, electrical discharge machining (EDM) and mechanical means.
- EDM electrical discharge machining
- Two materials found to be particularly suited to this application are implantable stainless steel, and Nickel-Titanium alloys such as Nitinol.
- each cell 20 of the endoprosthesis 24 may consist of two sides 54 having three curves 56 , and two inflection points 36 . Such a configuration produces almond-shaped cells. There may also be flat portions (not shown) designed into the cell 20 . These cells 20 are then designed on the thick walled cylinder 22 in a pattern which repeats along the length of the cylinder 22 . This pattern is then repeated with a longitudinal stagger of half a cell 20 around the circumference of the cylinder 22 . The pattern also includes half cells at each end of the tube. Upon removal of the cells 20 the remaining material constitutes the prosthesis 24 described herein.
- the prosthesis 24 may be formed from a thick walled cylinder 22 approximately the size of the compressed configuration 50 .
- This thick walled cylinder 22 may be a Nickel Titanium alloy.
- Cells 20 are laser cut into the thick walled cylinder 22 while the thick walled cylinder 22 is mounted over a wire.
- the cells 20 are formed in a long narrow configuration, with each of the curves 56 having large radii.
- the prosthesis 24 is cleaned and deburred to eliminate manufacturing irregularities. This may include blasting techniques, acid etching, ultrasonic cleaning and/or other well known methods of cleaning.
- the prosthesis may then be stretched into more expanded configurations.
- One method of expanding this prosthesis is by mechanically stretching it over a mandrel.
- the mandrel may be specifically designed with pins to maintain the desired curvature of the beams.
- Once stretched the prosthesis is annealed to set the new expanded shape of the prosthesis. Annealing can be accomplished by heating the prosthesis within a variety of media such as air, molten salt, inert gas or vacuum. Annealing at 500-550° C. is appropriate for Nickel-Titanium alloys.
- After stretching the prosthesis 24 is cleaned again. This process of stretching, annealing and cleaning can be repeated until the desired configuration is obtained. Once the desired configuration has been obtained, the prosthesis is electropolished by any of the well-known methods.
- a prosthesis 24 may be formed from a Nickel Titanium thick walled cylinder 22 approximately the size of expanded configuration. In this process cells 20 are cut into the thick walled cylinder in a shorter and wider configuration. This method would eliminate the need to stretch and anneal the prosthesis 24 to achieve the expanded configuration 94 .
- the beams of a prosthesis may embody variable widths beams or struts 70 and generally uniform width beams or struts 71 .
- the incorporation of variable width struts 70 into a prosthesis facilitates uniform expansion. For example, to achieve uniform expansion, it is desirable to have struts 70 of the same width meeting at connecting junctions 72 .
- Asymmetric prosthesis portions 74 , 76 as shown in FIGS. 12 and 13 may further require the strut 70 to embody a width that gradually varies along the length of the strut 70 .
- FIG. 12 As shown in FIG.
- the point of connection 82 , 83 between adjacent cells 80 may be varied in length, for example to accommodate a hole 84 .
- the struts 70 extending from a relatively shorter point of connection 82 between adjacent cells 80 can embody a tapering thickness.
- the novel features of the present invention may be applied to configure a prosthesis having variable properties throughout the length of the prosthesis.
- the flexibility of the prosthesis 24 may vary along the length of the prosthesis.
- connector elements 58 may be used to combine segments 90 of the prosthesis 24 .
- Each segment 90 may be composed of curved beams 26 in the various configurations described above.
- a segment 90 composed of full cells 20 may be combined with multiple segments 90 composed of half-cells 21 .
- the portion of the prosthesis 24 composed of half-cell 21 segments 90 will tend to be significantly more flexible longitudinally and slightly more flexible radially.
- the invention includes any combination of full cells and half-cells in a prosthesis including, but not limited to, full cells between half-cells.
- One application of a prosthesis 24 having variable flexibility throughout its length is for the support of a vascular graft 52 .
- the more flexible segments 90 of the prosthesis 24 may be configured to support the artificial lumen 46 of the graft 52 .
- the less flexible segment 90 of the prosthesis 24 may be configured to extend beyond the artificial lumen 46 and into the patients natural lumen. In this manner, the less flexible segments 90 help secure the graft 52 into place, while the more flexible segments 90 support the material of the graft 52 .
- the invention described herein may also embody features to facilitate the high ratios of expansion possible with this prosthesis 24 .
- the ends 92 of the beams 26 may be connected in a manner which evenly distributes the stresses incurred by expansion and compression.
- An eyelet or loop connector 94 may connect the ends of the beams 26 .
- These eyelet connectors 94 distribute stresses from compression of the prosthesis 94 .
- the bending and resultant stresses are initially concentrated in the eyelet or loop portion of the connector 94 .
- a contact area 96 is formed at the edge of the eyelet connector 24 .
- the prosthesis 24 is further compressed and adjacent beams 26 are brought even closer together, the bending and resulting stresses are now concentrated at the ends of the beams 26 near the contact area 96 . Even further compression may relieve the stresses in the eyelet connector 24 by creating a fulcrum at the contact area 96 .
- a prosthesis 24 composed entirely of eyelet connectors 94 , as depicted in FIG. 18, may facilitate the distribution of stresses induced by high expansion ratios.
- the prosthesis 24 of the present invention may be used in particularly large corporeal lumens, such as the abdominal aorta.
- This same prosthesis 24 may also be introduced into relatively small corporeal lumens, such as the femoral artery.
- Such an application requires the prosthesis to transition between a highly compressed state for insertion into the femoral artery, to a highly expanded state for implantation into the abdominal aorta.
- This application, as well as others, induce high stresses on the prosthesis 24 through bending of the beams 26 in expansion and compression.
- a similar distribution of the stresses may be accomplished by configuring the ends 92 of the beams 26 into increased contact end connectors 98 (FIGS. 17 a and 17 b ).
- the ends 92 of the beam 26 connect together with a substantial area of contact 96 near the actual connection.
- the contact area 96 expands as the beams 26 are brought closer together and the stress concentrations are thereby distributed along the length of the beams 26 .
- the prosthesis 24 of the present invention may be configured to pack tightly for compression into a collapsed state.
- One example, as depicted in FIGS. 19 and 20 may utilize eyelet connectors 94 aligned to differing heights. That is, every other eyelet connector 94 may be configured upon beams 26 of a first, greater length 100 , while each other eyelet connector 94 may be configured upon beams 26 of a second lesser length 102 .
- the eyelet connectors 94 configured upon beams at the second length would have their greatest width at the same location that the eyelet connectors 94 configured upon beams at the first length have their least width. In this manner the beams 26 and eyelet connectors 94 fit together in the most compact condition while compressed. Similar results may be accomplished by varying the thickness of the beams 26 and connectors 94 .
- Varying the circumferential width 42 of the beams 26 may also provide benefits in high expansion ratios. For example, using larger widths on beams 26 of a first, greater length 100 may help control the expansion of the prosthesis 24 and reduce stress concentrations. Varying the circumferential width 42 along the length of individual beams 26 may provide superior nesting when the prosthesis is provided with eyelet connectors 94 .
- FIG. 21 Further configurations, as depicted in FIG. 21, may be advantageous when the prosthesis 24 is configured for use in a vascular graft 52 .
- Eyelet connectors 94 may be used to provide an anchor for the stitching 104 between the graft 52 and the prosthesis 24 .
- the merge sections 28 at the end of the prosthesis may include a flattened bulbous tail 106 . These tails 106 reduce the wearing on the fabric of the graft 52 . Tails 106 may also help control the expansion of the prosthesis 24 . Instead of springing open when the ends of the prosthesis 24 are released, the tails 106 may remain constrained within a delivery catheter and provide the prosthesis 24 with a slower more controlled expansion.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Optics & Photonics (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
A new endoluminal prosthesis provides for a compressible and expansible single-piece thick walled cylindrical structure. The cylindrical structure is comprised of curved elongated beams which intermittently merge with adjacent curved elongated beams. Each beam has a radial thickness greater than the circumferential width. The configuration of the curved beams reduces stress concentrations in the expanded and compressed condition of the prosthesis. Features are provided for high expansion ratios allowing the prosthesis to collapse into a very small diameter and expand into a very large diameter.
Description
- This Application is a continuation-in-part of application Ser. No. 09/546,966 filed Apr. 11, 2000 entitled “Single Piece Thick-Walled Endoprosthesis.”
- This invention relates to medical devices for the treatment of vascular diseases generally referred to as endoluminal prostheses. A variety of such devices are available for a broad range of treatment modalities. Examples of such devices are “vascular grafts” and “stents.” Vascular grafts are typically used to treat weakened areas of vessels known as aneurysms. Stents are typically used to prop open a narrowed or stenosed vessel.
- Stents and grafts may be delivered intraluminally through a narrow incision or a puncture in the patient's skin. The device may be mounted on a delivery catheter and inserted into a corporeal lumen through the skin. The device and catheter are then advanced through the various lumens to the site to be treated. To accomplish this, stents and grafts are generally collapsible for delivery and expansible for treatment.
- Vascular grafts are primarily composed of an artificial lumen which isolates the natural lumen from the flow of bodily fluids, such as blood. Grafts may incorporate attachment devices to secure the graft into the natural lumen and keep the graft expanded. Stents are typically formed of metallic wire or bars configured in a cylinder. Prior art stents have generally taught that the resulting thickness of the cylinder should be kept small to provide as large of an open lumen as possible. They have also taught the use of wide bar elements to compress plaque or tissue and hold it against the lumen wall. These stents expand by configuring the elements of the cylindrical structure such that they bend from a generally longitudinal orientation while compressed to a more circumferential orientation while expanded. These bending elements are then connected by elements which typically lie and remain in a circumferential orientation. This configuration limits the compressibility of the prior art stents because elements in a circumferential orientation cannot be tightly packed and thin elements in a longitudinal orientation tend to overlap while compressed.
- The configuration of prior art stents causes stress concentrations by limiting the portions of the structure that bend during expansion and compression. These stents have taught the use of configurations which limit bending either to circumferential members or to the areas immediately about such members. Such configurations limit the ability of the prior art stents to expand through very high expansion ratios.
- At least one prior art device has incorporated the benefits of a cylindrical structure composed of flat wires. This device is described in U.S. Pat. No. 5,993,482 (Chuter) as a Flat-Wire Stent. The teachings of that patent are hereby incorporated by reference.
- The Chuter flat-wire stent teaches a stent comprised of flat-wires which results in a relatively thick-walled structure. This approach has proven to have many advantages. The Chuter flat-wire stent exhibits a greater expansion ratio than other prosthesis. This is due in part to superior packability when compressed. Other advantages include a reduction in stress concentrations while expanded and the minimizing of foreshortening during expansion.
- Briefly and in general terms, the present invention relates to an improved endoluminal prosthesis. This prosthesis may function as a stent or as a means to secure an endoluminal graft in a corporeal lumen such as an artery. Stents typically are used to ensure the patency of diseased corporeal lumens by resisting collapse and occlusion. Endoluminal grafts typically are used to isolate diseased corporeal lumens from the flow of bodily fluids.
- The prosthesis incorporating the present invention is configured as a series of intermittently merging curved beams (e.g. leaf springs) formed into a cylinder. This cylindrical structure is capable of being compressed into a small diameter and expanded into a large diameter. To facilitate both compression and expansion the beams have a cross-section which is greater in the radial direction (thickness) than in the circumferential direction (width). The beams of the present invention are also generally continuously curved to reduce or minimize stress concentrations in the structure. The beams straighten during compression until they are nearly straight.
- While compressed the thickness of the beams prevents overlap. In a tightly packed configuration, the curved beams straighten out, come together and generally lie flat in close proximity to each other. The beams resist overlap because the thickness of each beam requires substantial radial displacement to move over or under the adjacent beam. The compression of the prosthesis may be maximized by configuring the beams to fit together tightly in a collapsed condition.
- While expanded and during expansion, the thickness of the beams and the configuration of the beams increase the strength of the prosthesis and reduce or minimize stress concentrations. Thicker beams provide for more material in the radial direction to prevent radial collapse. The curved configuration of the beams spreads the bending due to expansion throughout the entire length of the beam. This prevents one area of the beam from generating most of the bending and withstanding resultant stress concentrations.
- In various preferred embodiments of the present invention, further improvements distribute stresses throughout the beams more evenly. For example, the extreme ends of adjacent beams may be connected by a loop or eyelet connector. In such an embodiment the stresses from bending due to compression of the prosthesis concentrate in the loop portion of the connector until the lower portion of the connector just adjacent to the loop portion closes on itself, bringing the adjacent beams into contact. Further compression after that point concentrates stresses in the beam below the loop. A similar result can be achieved by configuring the beams to form a significant area of contact adjacent other types of connectors prior to full compression of the prosthesis.
- The present invention is a single integrated structure without welds or fasteners. This may be accomplished by removing almond-shaped cells from a thick-walled cylinder. This eliminates the need to construct the prosthesis from individual pieces and possible weak points created by fasteners or joining.
- In a first embodiment, the prosthesis may have curved beams which are only merged to adjacent beams at their end points. This creates a single repetitive pattern around the circumference of the cylinder, with each beam merged to opposite adjacent beams at opposite end points. This embodiment may be viewed as the simplest structure to include the invention described herein. It includes alternating half-cells divided by curved beams. This embodiment is not necessarily short, as the beams may be of any length. However, it may be viewed as the shortest configuration for any given cell size.
- In a second embodiment, the prosthesis may have curved beams like leaf springs which are repeatedly merged to alternating adjacent beams throughout their length. This second embodiment may also be viewed as the single repetitive pattern of the first embodiment repeated throughout the length of the prosthesis. For example, a prosthesis may be comprised of two or more of the single pattern prosthesis connected end to end. Instead of actually connecting the prosthesis, they may be formed as a single structure. Thereby, the beams could be viewed as continuous throughout the length of the prosthesis. The beams would then have many curved portions which bring them in connection with alternating adjacent beams at merge sections.
- The prosthesis may also embody these curved beams forming individual cylindrical elements and connected together by separate elements. Thus, a variety of prosthesis may be formed by connecting different cylindrical elements together with different connecting elements. One configuration includes cylindrical elements having curved beams which are only merged to adjacent beams at their end points connected to cylindrical elements having curved beams which are repeatedly merged to alternating adjacent beams throughout their length. This provides a prosthesis having varying strength and flexibility throughout its length.
- In the compressed condition the prosthesis may be intraluminally inserted and delivered within a corporeal lumen. Once delivered to the site to be treated, the prosthesis may be expanded and imbedded into the interior of the lumen. Various methods for intraluminally expanding prostheses are well-known in the art. Expansion due to spring forces is particularly suited for this invention. The super-elastic properties of Nickel-Titanium alloys (for example Nitinol) allow a great amount of expansion and compression of structures without permanent deformation. Thus a prosthesis made of such material may be compressed into a very small configuration, and will spring back into a preset form when released. Other known methods of expansion include balloon expansion, and expansion due to the highly elastic properties of certain alloys.
- The present invention may also be balloon expandable. To expand the prosthesis by balloon an angioplasty-type dilation catheter is inserted through a compressed or not-fully expanded prosthesis until the balloon portion of the catheter is longitudinally aligned within the prosthesis. The balloon is then expanded forcing the prosthesis radially outwardly.
- Once expanded the prosthesis remains in the expanded condition, and the strength of the prosthesis resists radial collapse. When used alone the prosthesis can expand and resist re-collapse of a previously collapsed or stenosed corporeal lumen. When used in combination with a graft, the prosthesis can maintain the graft open and secure the graft to the vessel.
- Additional preferred embodiments of the present invention may provide benefits for high-expansion ratios. That is, the prosthesis may be configured to readily withstand high degrees of expansion and compression. Prostheses having loop or eyelet connectors according to this invention may also include beams of different lengths. Alternating pairs of beams having longer lengths and shorter lengths provide a more controlled expansion. This configuration also permits the eyelets of the shorter length beams to nestle below the eyelets of the longer length beams upon compression. A further feature aiding the expansion of the prosthesis includes varying the widths of the individual beams. For example, configuring beams having longer lengths with greater widths will improve the prosthesis ability to accomplish high expansion. Furthermore, varying the width along the length of the beam may also improve the expansion and compression abilities of prosthesis.
- Other configurations of the prosthesis may be beneficial when the prosthesis is used in combination with a graft. The ends of prosthesis which are to be configured within a graft may include a flattened bulbous tail. Such an extension of the prosthesis prevents wear on the fabric of the graft. Eyelets on the ends of the prosthesis may also be used for stitching the prosthesis together with the graft. Eyelets provide a good anchoring point for such stitching. Various combinations of connected prosthesis according to the present invention may be used within grafts.
- These and other advantages of the invention will become more apparent from the following detailed description of the preferred embodiments. When taken in conjunction with the accompanying exemplary drawings the person of skill in the art will appreciate that various embodiments incorporate the present invention.
- FIG. 1 is a perspective view of a first embodiment of the prosthesis in an expanded condition.
- FIG. 2 is a perspective view of the first embodiment of the prosthesis in a compressed condition.
- FIG. 3 is a cross-sectional view of the first embodiment of the prosthesis in an expanded condition.
- FIG. 4 is a cross-sectional view of the first embodiment of the prosthesis in a compressed condition.
- FIG. 5 is a perspective view of a second embodiment of the prosthesis.
- FIG. 6 is a side view of a third embodiment of the prosthesis.
- FIG. 7 is a top view of a portion of a flat pattern for the prosthesis.
- FIG. 8 is a side view of a fourth embodiment of the prosthesis.
- FIG. 9 is a side view of a vascular graft secured in a corporeal lumen by a prosthesis.
- FIG. 10 is a side view of a prosthesis embedded in a corporeal lumen.
- FIG. 11 is a perspective view of a thick-walled cylindrical tube with cells designed therein.
- FIG. 12 is a flat pattern view of a portion of a prosthesis embodying variable thickness beams.
- FIG. 13 is a flat pattern view of a portion of a prosthesis including alternative embodiments of variable thickness beams.
- FIG. 14 is a flat pattern view of a portion of a prosthesis including additional alternative embodiments of variable thickness beams.
- FIG. 15 is a flat pattern view of a portion of a prosthesis including additional alternative embodiments having varying flexibility.
- FIGS. 16a and 16 b are side views of a first alternative embodiment of the beam ends and connector.
- FIGS. 17a and 17 b are side views of a second alternative embodiment of the beam ends and connector.
- FIG. 18 is a flat pattern view of a first embodiment of a prosthesis having the alternative beam end connectors shown in FIGS. 16a and 16 b.
- FIG. 19 is a flat pattern view of a second embodiment of a prosthesis having the alternative beam end connectors shown in FIGS. 16a and 16 b.
- FIG. 20 is a flat pattern view of the prosthesis of FIG. 19 in a collapsed state.
- FIG. 21 is a flat pattern view of a prosthesis from within a vascular graft.
- The following description, as well as the Figures, describe embodiments of the invention. These embodiments are exemplary of the inventors known uses of the invention, and are not intended to limit the scope of the claimed invention. Those skilled in the art of endoluminal devices will appreciate that the invention described herein may encompass many embodiments.
- As shown in the Figures, the present invention relates to an endoluminal prosthesis. More particularly, the invention is an expandable and compressible prosthesis for repairing corporeal lumens. The prosthesis may be formed from a metallic cylinder by removal of cells.
- As depicted in FIGS. 1 and 2, the result of removing
cells 20 from themetallic cylinder 22 is aprosthesis 24 having a series ofcurved beams 26 and mergesections 28. It is to be recognized that theprosthesis 24 shown in FIG. 2 can be compressed, where desired, to a smaller diameter such that thecells 20 are essentially defined by slits (not shown). - The
beams 26 are generally longitudinal members circumferentially spaced about theprosthesis 24. In one embodiment, as depicted in FIG. 5, the ends of thesebeams 26 merge with the ends of circumferentially adjacent beams to form themerge sections 28 only at the ends of the prosthesis. The ends of eachbeam 26 merge with one adjacent beam on theforward end 30 and the opposite adjacent beam on therear end 32. This creates a single circumferential pattern of staggered half-cells 21 divided by beams 26. (For comparison, afull cell 25 is identified in FIG. 1). Preferably, thebeams 26 each include at least twocurved segments 34 of opposite orientations and aninflection point 36 near the mid-point of the beams. - In the embodiment depicted in FIG. 5, the
merge sections 28 include either the forward ends 30 orrear ends 32 of twosuch beams 26 as well as the ends of the prosthesis. These mergesections 28 are also circumferentially spaced about theprosthesis 24, preferably equidistantly. - The single pattern as depicted in FIG. 5 may be extended to build
longer prostheses 24. This may be done by extending the length of eachbeam 26 with additionalcurved segments 34 and formingadditional merge sections 28. This forms theprosthesis 24 as depicted in FIGS. 1 and 2. Alternatively, multiple single patterns may be connected with aseparate connector element 58. Theconnector elements 58 may have various configurations and be distributed throughout theprosthesis 24 in a variety of arrangements. Such aprosthesis 24, having “S”-shaped connector elements at each merge section is depicted in FIG. 6. Other embodiments (not shown) may have connectors with other shapes only at every second or third merge section. Such embodiments may have advantages in providing longitudinal flexibility to theprosthesis 24. - In the embodiments depicted in FIGS. 1 and 2 the
beams 26 may extend beyond thefirst merge sections 28 to formadditional merge sections 28. This configuration may also be viewed as themerge sections 28 connected end-to-end with opposite facingmerge sections 28. This may provide for aprosthesis 24 of greater lengths. Thecontinuous beams 26 of this embodiment merge withadjacent beams 26 repeatedly and alternately throughout their length. The continuous beams are comprised of multiplecurved segments 34. Themerge sections 28 may also contain flat segments (not shown). - As depicted in FIGS. 3 and 4 the
prosthesis 24 is preferably formed from a thick-walled cylinder 22. The difference between the external radius of the cylinder and the internal radius of the cylinder defines aradial thickness 40. Preferably, thecells 20 of theprosthesis 24 are removed such that the remainingbeams 26 have a width (measured circumferentially) 42 that is less than theradial thickness 40. A typical design might have dimensions of 0.007″circumferential width 42 and 0.014″radial thickness 40. This defines a deep cross-section for thebeams 26. To take advantage of the benefits of this invention, theradial thickness 40 of thebeams 26 needs to be substantially greater than thecircumferential width 42. Preferably, theradial thickness 40 will be at least one and one-third (1⅓) times thecircumferential width 42. - A theoretical flat pattern of the
beams 26 and mergesections 28, as depicted in FIG. 7 reveals the novel configuration of the beams. Preferably, eachbeam 26 is continuously curved, alternating betweencurves 56 of opposite orientations throughout its length. In this ideal configuration, thebeams 26form inflection points 36 between the opposite facing curves 56. - Each
curve 56 in eachbeam 26 is defined by two radii, aninternal radius 64 and anexternal radius 66. The difference between these radii define thecircumferential width 42 of thebeam 26. - The continuously curved configuration of
beams 26 disposed longitudinally along a cylinder, provides some of the unique properties of this invention. As the cylinder is expanded from a partially compressedconfiguration 50, the radii of eachcurve 56 within eachbeam 26 becomes smaller as the beams spread apart. Since thebeams 26 are ideally continuously curved, the bending is spread throughout the entire length of thebeam 26. This spreads the resultant stresses throughout thebeam 26 and reduced or minimizes stress concentrations. - As depicted in FIGS. 2 and 4 the use of deep cross-sections has significant advantages for collapsing the
prosthesis 24 in preparation of intraluminal delivery. The deep cross-section allows for significant compression without incidental overlapping of thebeams 26. Thelarge radial thickness 40 of thebeams 26 prevents one beam from extending over the top of another. - As depicted in FIGS. 1 and 3 there are also advantages to the use of deep cross-sections in expansion of the
prosthesis 24. In general, as cylindrical, expandable prosthesis are expanded, longitudinally-oriented members of the collapsed prosthesis tend to bend circumferentially. The relatively narrow width of thebeams 26 of thepresent prosthesis 24 permits circumferential bending without inducing high stress concentrations. The large overall cross-sectional area of thebeams 26 prevents recompression of theprosthesis 24. The configuration of thecurved segments 34 spreads the stresses induced by expansion across the entire length of thebeams 26, also reducing stress concentrations. In a preferred embodiment, the prosthesis is self-expandable. Alternatively, the prosthesis may be expanded by balloon. - FIGS. 1 and 3 and FIGS. 2 and 4 depict two separate configurations of the
prosthesis 24. Theprosthesis 24 of the present invention has an expandedconfiguration 44 while deployed in the lumen as depicted in FIGS. 1 and 3. This configuration has a large inner diameter which allows maximum patency of thelumen 46 to be treated. Theprosthesis 24 of the present invention also has a second partialcompressed configuration 50 as depicted in FIGS. 2 and 4. This configuration is beneficial to the intraluminal delivery of the device which is facilitated by a smaller external diameter. - In a typical procedure the
prosthesis 24 will be constrained in thecompressed configuration 50 within a catheter. This catheter may then be inserted into asmall diameter lumen 46 such as the femoral artery. To prevent damage to such an artery the entire system of catheter andprosthesis 24 must have as small a diameter as possible. Small diameters also facilitate the navigation of theprosthesis 24 and catheter through arduous vasculature. Once inserted into such an artery, the catheter andprosthesis 24 may be advanced through the corporeal lumens, possibly to larger arteries for treatment. Theprosthesis 24 may then be released from the catheter. Spring forces within the compressed prosthesis of a self-expanding version will force the prosthesis from the partially compressedconfiguration 50 into the expandedconfiguration 44. The spring forces may be great enough to expand the lumen of the diseased vessel as theprosthesis 24 expands. These forces will also be great enough to impinge thebeams 26 into the tissues of the vessel. This impinging secures theprosthesis 24 and possibly an associatedgraft 52 into place. - Another embodiment of the
prosthesis 24, depicted in FIG. 8, has a conical rather than cylindrical shape while in the expandedconfiguration 44. In this embodiment, theprosthesis 24 has a cylindrical shape in thecompressed configuration 50. Upon expansion, however, abroader end 60 of theprosthesis 24 expands more than anarrower end 62. This conical embodiment of theprosthesis 24 is useful in similarly shaped lumens and various configurations of grafts. Thebroader end 60 may includecells 20 that are longer and wider in the expandedconfiguration 44, than those at thenarrower end 62. - The
prosthesis 24 of the current invention may be used in a variety of procedures, two of which are depicted in FIGS. 9 and 10. As depicted in FIG. 9 one or more prostheses embodying the present invention may be used in the treatment of aneurysms. An aneurysm is a weakening of the vessel wall of a vein or artery, causing a sack to form in thelumen 46 or possibly rupture. When an aneurysm forms in the abdominal aorta, the condition can be life-threatening. A known treatment for aneurysms is the intraluminal delivery and implantation of avascular graft 52. Such agraft 52 bypasses the sack formed by the aneurysm and isolates the weakened tissues from the blood flow. To operate properly, thegraft 52 must have leak-proof fixation to the healthy vascular tissue on either side of the aneurysm. Theprosthesis 24 described herein may provide that fixation at one or more ends of thegraft 52. Theprosthesis 24 may also extend throughout the length of thegraft 52. When expanded theprosthesis 24 may compress theflexible graft material 52 against the arterial wall. Preferably, theprosthesis 24 extends further from the aneurysm than thegraft 52 so that parts of theprosthesis 24 are imbedded in healthy tissue. This configuration maintains the patency of the artificial lumen of thegraft 52 as well as securing the graft in place by forcing the end of the graft against the wall of thelumen 46. Theprosthesis 24 also ensures a leak-proof seal. - As depicted in FIG. 10, a
prosthesis 24 embodying the present invention may be used to treat a stenosis or collapse of thelumen 46. Stenosis is often caused by the gradual occlusion of veins or arteries through the build-up of plaque. Preferably asingle prosthesis 24 is inserted into the diseased vessel while mounted within a catheter. When theprosthesis 24 is at the location of the narrowing, theprosthesis 24 may be expanded. As depicted in FIG. 10 the spring forces of the prosthesis are preferably sufficient to expand the narrowed vessel. Theprosthesis 24 is thereby forced into the tissues of thelumen 46 to secure theprosthesis 24 in place. The structure of theprosthesis 24 resists collapse after expansion. - The
prosthesis 24 may be manufactured in thecompressed configuration 50 as in FIG. 2, or in the expandedconfiguration 44 as in FIG. 1 or in any configuration in between. The manufacturing procedure requires the removal ofcells 20 from a thick-walled cylinder 22. This may be accomplished with several known manufacturing methods such as laser cutting, chemical etching, photo-etching, electrical discharge machining (EDM) and mechanical means. Two materials found to be particularly suited to this application are implantable stainless steel, and Nickel-Titanium alloys such as Nitinol. - As depicted in FIG. 11, each
cell 20 of theendoprosthesis 24 may consist of twosides 54 having threecurves 56, and twoinflection points 36. Such a configuration produces almond-shaped cells. There may also be flat portions (not shown) designed into thecell 20. Thesecells 20 are then designed on the thickwalled cylinder 22 in a pattern which repeats along the length of thecylinder 22. This pattern is then repeated with a longitudinal stagger of half acell 20 around the circumference of thecylinder 22. The pattern also includes half cells at each end of the tube. Upon removal of thecells 20 the remaining material constitutes theprosthesis 24 described herein. - The
prosthesis 24 may be formed from a thickwalled cylinder 22 approximately the size of the compressedconfiguration 50. This thickwalled cylinder 22 may be a Nickel Titanium alloy.Cells 20 are laser cut into the thickwalled cylinder 22 while the thickwalled cylinder 22 is mounted over a wire. Thecells 20 are formed in a long narrow configuration, with each of thecurves 56 having large radii. - After the
cells 20 are cut into the thickwalled cylinder 22, theprosthesis 24 is cleaned and deburred to eliminate manufacturing irregularities. This may include blasting techniques, acid etching, ultrasonic cleaning and/or other well known methods of cleaning. - The prosthesis may then be stretched into more expanded configurations. One method of expanding this prosthesis is by mechanically stretching it over a mandrel. The mandrel may be specifically designed with pins to maintain the desired curvature of the beams. Once stretched the prosthesis is annealed to set the new expanded shape of the prosthesis. Annealing can be accomplished by heating the prosthesis within a variety of media such as air, molten salt, inert gas or vacuum. Annealing at 500-550° C. is appropriate for Nickel-Titanium alloys. After stretching the
prosthesis 24 is cleaned again. This process of stretching, annealing and cleaning can be repeated until the desired configuration is obtained. Once the desired configuration has been obtained, the prosthesis is electropolished by any of the well-known methods. - Alternatively, a
prosthesis 24 may be formed from a Nickel Titanium thickwalled cylinder 22 approximately the size of expanded configuration. In thisprocess cells 20 are cut into the thick walled cylinder in a shorter and wider configuration. This method would eliminate the need to stretch and anneal theprosthesis 24 to achieve the expandedconfiguration 94. - As best seen in FIGS.12-14, it is also contemplated that the beams of a prosthesis may embody variable widths beams or struts 70 and generally uniform width beams or struts 71. The incorporation of variable width struts 70 into a prosthesis facilitates uniform expansion. For example, to achieve uniform expansion, it is desirable to have
struts 70 of the same width meeting at connectingjunctions 72.Asymmetric prosthesis portions strut 70 to embody a width that gradually varies along the length of thestrut 70. Moreover, as shown in FIG. 14, where aprosthesis portion 78 embodies a plurality of adjacent orientedcells 80, the point ofconnection adjacent cells 80 may be varied in length, for example to accommodate ahole 84. To facilitate uniform expansion of such aprosthesis portion 78, thestruts 70 extending from a relatively shorter point ofconnection 82 betweenadjacent cells 80 can embody a tapering thickness. - The novel features of the present invention may be applied to configure a prosthesis having variable properties throughout the length of the prosthesis. As an example, and as depicted in FIG. 15, the flexibility of the
prosthesis 24 may vary along the length of the prosthesis. To accomplish this,connector elements 58 may be used to combinesegments 90 of theprosthesis 24. Eachsegment 90 may be composed ofcurved beams 26 in the various configurations described above. In a preferred embodiment, asegment 90 composed offull cells 20 may be combined withmultiple segments 90 composed of half-cells 21. The portion of theprosthesis 24 composed of half-cell 21segments 90 will tend to be significantly more flexible longitudinally and slightly more flexible radially. The invention includes any combination of full cells and half-cells in a prosthesis including, but not limited to, full cells between half-cells. - One application of a
prosthesis 24 having variable flexibility throughout its length is for the support of avascular graft 52. In such an application, the moreflexible segments 90 of theprosthesis 24 may be configured to support theartificial lumen 46 of thegraft 52. The lessflexible segment 90 of theprosthesis 24 may be configured to extend beyond theartificial lumen 46 and into the patients natural lumen. In this manner, the lessflexible segments 90 help secure thegraft 52 into place, while the moreflexible segments 90 support the material of thegraft 52. - The invention described herein may also embody features to facilitate the high ratios of expansion possible with this
prosthesis 24. As depicted in FIGS. 16a and 16 b, as well as FIGS. 17a and 17 b, the ends 92 of thebeams 26 may be connected in a manner which evenly distributes the stresses incurred by expansion and compression. - An eyelet or loop connector94 (shown in FIGS. 16a and 16 b) may connect the ends of the
beams 26. Theseeyelet connectors 94 distribute stresses from compression of theprosthesis 94. As theprosthesis 24 is initially compressed andadjacent beams 26 are brought together, the bending and resultant stresses are initially concentrated in the eyelet or loop portion of theconnector 94. Eventually, acontact area 96 is formed at the edge of theeyelet connector 24. As theprosthesis 24 is further compressed andadjacent beams 26 are brought even closer together, the bending and resulting stresses are now concentrated at the ends of thebeams 26 near thecontact area 96. Even further compression may relieve the stresses in theeyelet connector 24 by creating a fulcrum at thecontact area 96. - A
prosthesis 24 composed entirely ofeyelet connectors 94, as depicted in FIG. 18, may facilitate the distribution of stresses induced by high expansion ratios. Thus, theprosthesis 24 of the present invention may be used in particularly large corporeal lumens, such as the abdominal aorta. Thissame prosthesis 24 may also be introduced into relatively small corporeal lumens, such as the femoral artery. Such an application requires the prosthesis to transition between a highly compressed state for insertion into the femoral artery, to a highly expanded state for implantation into the abdominal aorta. This application, as well as others, induce high stresses on theprosthesis 24 through bending of thebeams 26 in expansion and compression. - A similar distribution of the stresses may be accomplished by configuring the
ends 92 of thebeams 26 into increased contact end connectors 98 (FIGS. 17a and 17 b). In such a configuration (depicted in FIGS. 17a and 17 b), the ends 92 of thebeam 26 connect together with a substantial area ofcontact 96 near the actual connection. As theprosthesis 24 is compressed, and thebeams 26 are brought closer together, the stresses due to bending are concentrated in thebeams 26 near thecontact area 96. Thecontact area 96 expands as thebeams 26 are brought closer together and the stress concentrations are thereby distributed along the length of thebeams 26. - To further support high expansion ratios, the
prosthesis 24 of the present invention may be configured to pack tightly for compression into a collapsed state. One example, as depicted in FIGS. 19 and 20 may utilizeeyelet connectors 94 aligned to differing heights. That is, everyother eyelet connector 94 may be configured uponbeams 26 of a first,greater length 100, while eachother eyelet connector 94 may be configured uponbeams 26 of a secondlesser length 102. Thus theeyelet connectors 94 configured upon beams at the second length would have their greatest width at the same location that theeyelet connectors 94 configured upon beams at the first length have their least width. In this manner thebeams 26 andeyelet connectors 94 fit together in the most compact condition while compressed. Similar results may be accomplished by varying the thickness of thebeams 26 andconnectors 94. - Varying the
circumferential width 42 of thebeams 26 may also provide benefits in high expansion ratios. For example, using larger widths onbeams 26 of a first,greater length 100 may help control the expansion of theprosthesis 24 and reduce stress concentrations. Varying thecircumferential width 42 along the length ofindividual beams 26 may provide superior nesting when the prosthesis is provided witheyelet connectors 94. - Further configurations, as depicted in FIG. 21, may be advantageous when the
prosthesis 24 is configured for use in avascular graft 52.Eyelet connectors 94 may be used to provide an anchor for thestitching 104 between thegraft 52 and theprosthesis 24. Themerge sections 28 at the end of the prosthesis may include a flattenedbulbous tail 106. Thesetails 106 reduce the wearing on the fabric of thegraft 52.Tails 106 may also help control the expansion of theprosthesis 24. Instead of springing open when the ends of theprosthesis 24 are released, thetails 106 may remain constrained within a delivery catheter and provide theprosthesis 24 with a slower more controlled expansion. - While the present invention has been described herein in terms of a prosthesis for the repair of blood vessels, those of skill in the art will readily recognize that prostheses embodying the described invention can be used to treat a variety of corporeal lumens, for example the bronchial tree and intestines. The invention described herein is intended to be limited only by the claims that follow and not by any particular embodiment.
Claims (25)
1. A collapsible cylindrical endoprosthesis comprising:
a plurality of longitudinal members in a cylindrical arrangement, each having at least one end;
a plurality of circumferential members connecting the ends of adjacent longitudinal members; and
a plurality of opposed contact surfaces on adjacent longitudinal members near the circumferential members, with the opposed surfaces being oriented relative to each other, wherein, as the endoprosthesis is collapsed, the circumferential members bend until the opposed contact surfaces come together and then continued deflection of the longitudinal members produces stress at the contact surfaces.
2. The collapsible cylindrical endoprosthesis of claim 1 , wherein the manner of bending distributes the stresses throughout the longitudinal members and circumferential members.
3. The collapsible cylindrical endoprosthesis of claim 1 , wherein the circumferential members comprise a loop.
4. The collapsible cylindrical endoprosthesis of claim 1 , wherein the circumferential members comprise an eyelet configuration.
5. The collapsible cylindrical endoprosthesis of claim 1 , wherein the circumferential members comprise a merge section of the ends of adjacent longitudinal members.
6. The collapsible cylindrical endoprosthesis of claim 1 , wherein the longitudinal members further comprise a width measured circumferentially and a thickness measured radially wherein the thickness is greater than the width.
7. A collapsible cylindrical endoprosthesis comprising:
a plurality of longitudinal members arranged adjacently into a cylindrical configuration each having a first end section, a middle section and a second end section;
a first a plurality of eyelets connecting adjacent longitudinal members at the first end sections;
a second plurality of eyelets connecting adjacent longitudinal members at the second end sections; and
a plurality of merge sections connecting adjacent longitudinal members at the middle section.
8. The collapsible cylindrical endoprosthesis of claim 7 , wherein the first plurality of eyelets and the second plurality of eyelets connect the same longitudinal members forming pairs of longitudinal members connected at both the first ends and second ends.
9. The collapsible cylindrical endoprosthesis of claim 7 , further comprising:
opposed contact surfaces on the longitudinal members near the first plurality of eyelets and the second plurality of eyelets wherein the contact surfaces come together when the prosthesis is collapsed.
10. The collapsible cylindrical endoprosthesis of claim 9 , wherein the first plurality of eyelets and the second plurality of eyelets bend while the endoprosthesis is collapsed until the contact surfaces come together and the longitudinal members bend thereafter.
11. The collapsible cylindrical endoprosthesis of claim 7 , wherein the stresses due to collapsing the endoprosthesis are distributed between the longitudinal members, the first plurality of eyelets and the second plurality of eyelets.
12. The collapsible cylindrical endoprosthesis of claim 8 , wherein alternating pairs of longitudinal members define a first longer length between the first end section and the middle section and a second shorter length between the first end section and the middle section.
13. The collapsible cylindrical endoprosthesis of claim 12 , wherein alternating pairs of longitudinal members define a first longer length between the second end section and middle section, and a second shorter length between the second end section and the middle section.
14. The collapsible cylindrical endoprosthesis of claim 12 , wherein upon collapsing the endoprosthesis the eyelets connecting alternating pairs of longitudinal members defining the second shorter length nestle below the eyelets connecting alternating pairs of longitudinal members defining the first longer length.
15. The collapsible cylindrical endoprosthesis of claim7, wherein each longitudinal member defines a width measured circumferentially and a thickness measured radially, wherein the thickness is greater than the width.
16. A compressible endoprosthesis configured to secure an endoluminal graft within a body lumen, comprising:
a plurality of curved beams arranged longitudinally in a cylindrical structure, each beam having at least one end;
a plurality of merge sections formed by adjacent curved beams merging together;
at least one eyelet formed in a merge section at the ends of adjacent curved beams; and
wherein at least one eyelet provides an anchor for stitching the endoprosthesis to the endoluminal graft.
17. The endoprosthesis of claim 16 , further comprising:
opposed contact surfaces on the curved beams near the at least one eyelet, wherein the contact surfaces come together when the endoprosthesis is compressed.
18. The endoprosthesis of claim 16 , wherein the at least one eyelet is configured to distribute stress throughout the curved beams while the endoprosthesis is compressed.
19. An expandable endoprosthesis comprising:
a plurality of curved beams arranged longitudinally in a cylindrical structure, each beam having at least one end;
a plurality of merge sections formed by adjacent curved beams merging together; and
at least one bulbous extension formed in a merge section at the ends of adjacent curved beams.
20. The endoprosthesis of claim 19 , wherein the endoprosthesis is formed from a single integral structure.
21. A collapsible cylindrical endoprosthesis comprising:
a plurality of curved longitudinal members in a cylindrical arrangement, each having a proximal end and a distal end;
a plurality of proximal connections integrally formed by the proximal ends of adjacent longitudinal members;
a plurality of distal connections integrally formed by the distal ends of adjacent longitudinal members; and
the cylindrical endoprosthesis has a first diameter sized to compress against the interior of a corporeal lumen and a second smaller diameter sized to fit within a delivery catheter;
wherein the cylindrical endoprosthesis withstands stresses induced by collapsing through bending of the curved longitudinal members.
22. The collapsible cylindrical endoprosthesis of claim 21 , wherein the proximal connections further comprise a looped configuration.
23. The collapsible cylindrical endoprosthesis of claim 21 , wherein the distal connections further comprise a looped configuration.
24. The collapsible cylindrical endoprosthesis of claim 21 , wherein the plurality of curved longitudinal members further comprise pairs of opposed contact surfaces on adjacent members.
25. The collapsible cylindrical endoprosthesis of claim 21 , further comprising:
a plurality of bulbous extensions attached at the ends of the connections.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/837,353 US20020049490A1 (en) | 2000-04-11 | 2001-04-17 | Single-piece endoprosthesis with high expansion ratios |
US10/090,473 US6942690B1 (en) | 2000-04-11 | 2002-03-04 | Single-piece endoprosthesis with high expansion ratios and atraumatic ends |
US11/110,999 US7740653B1 (en) | 2000-04-11 | 2005-04-20 | Single-piece endoprosthesis with high expansion ratios and atraumatic ends |
US12/818,950 US8382816B2 (en) | 2000-04-11 | 2010-06-18 | Single-piece endoprosthesis with high expansion ratios and atraumatic ends |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54696600A | 2000-04-11 | 2000-04-11 | |
US09/837,353 US20020049490A1 (en) | 2000-04-11 | 2001-04-17 | Single-piece endoprosthesis with high expansion ratios |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US54696600A Continuation-In-Part | 2000-04-11 | 2000-04-11 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/090,473 Continuation-In-Part US6942690B1 (en) | 2000-04-11 | 2002-03-04 | Single-piece endoprosthesis with high expansion ratios and atraumatic ends |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020049490A1 true US20020049490A1 (en) | 2002-04-25 |
Family
ID=34915588
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/837,353 Abandoned US20020049490A1 (en) | 2000-04-11 | 2001-04-17 | Single-piece endoprosthesis with high expansion ratios |
US10/090,473 Expired - Fee Related US6942690B1 (en) | 2000-04-11 | 2002-03-04 | Single-piece endoprosthesis with high expansion ratios and atraumatic ends |
US11/110,999 Expired - Fee Related US7740653B1 (en) | 2000-04-11 | 2005-04-20 | Single-piece endoprosthesis with high expansion ratios and atraumatic ends |
US12/818,950 Expired - Fee Related US8382816B2 (en) | 2000-04-11 | 2010-06-18 | Single-piece endoprosthesis with high expansion ratios and atraumatic ends |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/090,473 Expired - Fee Related US6942690B1 (en) | 2000-04-11 | 2002-03-04 | Single-piece endoprosthesis with high expansion ratios and atraumatic ends |
US11/110,999 Expired - Fee Related US7740653B1 (en) | 2000-04-11 | 2005-04-20 | Single-piece endoprosthesis with high expansion ratios and atraumatic ends |
US12/818,950 Expired - Fee Related US8382816B2 (en) | 2000-04-11 | 2010-06-18 | Single-piece endoprosthesis with high expansion ratios and atraumatic ends |
Country Status (1)
Country | Link |
---|---|
US (4) | US20020049490A1 (en) |
Cited By (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030120338A1 (en) * | 2001-12-20 | 2003-06-26 | Chobotov Michael V. | Advanced endovascular graft |
US20040093073A1 (en) * | 2002-05-08 | 2004-05-13 | David Lowe | Endoprosthesis having foot extensions |
US20040093072A1 (en) * | 2002-05-06 | 2004-05-13 | Jeff Pappas | Endoprosthesis for controlled contraction and expansion |
US20040193178A1 (en) * | 2003-03-26 | 2004-09-30 | Cardiomind, Inc. | Multiple joint implant delivery systems for sequentially-controlled implant deployment |
US20050107865A1 (en) * | 2003-05-06 | 2005-05-19 | Anton Clifford | Endoprosthesis having foot extensions |
US20050209675A1 (en) * | 2004-03-02 | 2005-09-22 | Ton Dai T | Corewire actuated delivery system with fixed distal stent-carrying extension |
US20050228484A1 (en) * | 2004-03-11 | 2005-10-13 | Trivascular, Inc. | Modular endovascular graft |
US20050273157A1 (en) * | 2004-06-08 | 2005-12-08 | Gregory Pinchasik | Stent having struts with reverse direction curvature |
US20060015173A1 (en) * | 2003-05-06 | 2006-01-19 | Anton Clifford | Endoprosthesis having foot extensions |
WO2006044147A2 (en) * | 2004-10-14 | 2006-04-27 | Cardiomind, Inc. | Small vessel stent designs |
US20060161243A1 (en) * | 2004-12-09 | 2006-07-20 | Cook Group Patent Office | S-shaped stent design |
US20070021834A1 (en) * | 2003-05-06 | 2007-01-25 | Eugene Young | Endoprosthesis having foot extensions |
US20070043419A1 (en) * | 2003-03-26 | 2007-02-22 | Cardiomind, Inc. | Implant delivery technologies |
US20070043424A1 (en) * | 2005-08-17 | 2007-02-22 | Medtronic Vascular, Inc. | Recapturable stent with minimum crossing profile |
US20070073379A1 (en) * | 2005-09-29 | 2007-03-29 | Chang Jean C | Stent delivery system |
US20070185560A1 (en) * | 2005-11-28 | 2007-08-09 | Cook Incorporated | Expandable stent |
US20080114447A1 (en) * | 2003-03-11 | 2008-05-15 | Boston Scientific Scimed, Inc. | Covered stent |
US20080262601A1 (en) * | 2002-09-13 | 2008-10-23 | Cully Edward H | Stent Device with Multiple Helix Construction |
WO2009085190A1 (en) * | 2007-12-26 | 2009-07-09 | Med Institute, Inc. | Stent and method of making a stent |
US7771463B2 (en) | 2003-03-26 | 2010-08-10 | Ton Dai T | Twist-down implant delivery technologies |
US20100228338A1 (en) * | 1998-03-27 | 2010-09-09 | Ev3 Inc. | Stents with tapered struts |
US7803178B2 (en) | 2004-01-30 | 2010-09-28 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
US7862602B2 (en) | 2005-11-02 | 2011-01-04 | Biosensors International Group, Ltd | Indirect-release electrolytic implant delivery systems |
US20110009941A1 (en) * | 2009-07-08 | 2011-01-13 | Concentric Medical, Inc. | Vascular and bodily duct treatment devices and methods |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US8361136B2 (en) | 1998-02-09 | 2013-01-29 | Trivascular, Inc. | Endovascular graft |
US8657870B2 (en) | 2009-06-26 | 2014-02-25 | Biosensors International Group, Ltd. | Implant delivery apparatus and methods with electrolytic release |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
JP5550028B1 (en) * | 2014-01-27 | 2014-07-16 | 株式会社World Medish | High flexibility stent |
WO2014081564A3 (en) * | 2012-11-20 | 2014-07-17 | Medtronic Inc. | Valve prosthesis frames |
JP5586742B1 (en) * | 2013-06-28 | 2014-09-10 | 株式会社World Medish | High flexibility stent |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
US10159557B2 (en) | 2007-10-04 | 2018-12-25 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
KR20190109752A (en) * | 2017-02-02 | 2019-09-26 | 씨. 알. 바드, 인크. | Short stent |
CN113229995A (en) * | 2021-04-08 | 2021-08-10 | 温州医科大学附属第二医院(温州医科大学附属育英儿童医院) | Self-expanding intrabody absorption biliary tract stent |
CN118267208A (en) * | 2024-04-11 | 2024-07-02 | 重庆医科大学附属第一医院 | Peripheral arterial support |
EP4212133A4 (en) * | 2020-09-11 | 2024-09-25 | JMR Co., Ltd. | STENT AND METHOD FOR PRODUCING STENT |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040102831A1 (en) * | 2002-11-22 | 2004-05-27 | Murray Robert J. | Stent having tapered edges |
JP2006520786A (en) | 2003-03-14 | 2006-09-14 | シネクサス, インコーポレイテッド | Sinus delivery of sustained-release therapeutic agents |
JP4546481B2 (en) * | 2003-09-30 | 2010-09-15 | アルヴィオラス,インコーポレイテッド | Removable stent |
DE102004012981B4 (en) * | 2004-03-16 | 2009-01-02 | Alveolus Inc. | stent |
EP1767240B1 (en) * | 2004-06-25 | 2014-05-21 | Zeon Corporation | Stent |
RU2007140909A (en) | 2005-04-04 | 2009-05-20 | Синексус, Инк. (Us) | DEVICE AND METHODS FOR TREATING DISEASES OF THE NANOLAIN SINUS |
US8262721B2 (en) * | 2005-05-13 | 2012-09-11 | Merit Medical Systems, Inc. | Drainage stent and associated method |
KR100776686B1 (en) * | 2006-05-11 | 2007-11-28 | 재단법인서울대학교산학협력재단 | Braided Stent and Manufacturing Method Thereof |
AU2007310953B2 (en) * | 2006-10-21 | 2013-05-02 | Celonova Stent, Inc | Deformable lumen support devices and methods of use |
US8974514B2 (en) * | 2007-03-13 | 2015-03-10 | Abbott Cardiovascular Systems Inc. | Intravascular stent with integrated link and ring strut |
EP3791826B1 (en) | 2007-12-18 | 2025-01-29 | Intersect ENT, Inc. | Self-expanding devices |
AU2009276505B2 (en) | 2008-08-01 | 2015-04-23 | Intersect Ent, Inc. | Methods and devices for crimping self-expanding devices |
US8403983B2 (en) | 2008-09-29 | 2013-03-26 | Cardiaq Valve Technologies, Inc. | Heart valve |
US8337541B2 (en) | 2008-10-01 | 2012-12-25 | Cardiaq Valve Technologies, Inc. | Delivery system for vascular implant |
EP4119098A1 (en) | 2009-04-15 | 2023-01-18 | Edwards Lifesciences CardiAQ LLC | Vascular implant and delivery system |
AU2010248992B2 (en) | 2009-05-15 | 2014-11-27 | Intersect Ent, Inc. | Expandable devices and methods therefor |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US20110224785A1 (en) | 2010-03-10 | 2011-09-15 | Hacohen Gil | Prosthetic mitral valve with tissue anchors |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
USD653341S1 (en) * | 2010-09-20 | 2012-01-31 | St. Jude Medical, Inc. | Surgical stent |
USD660432S1 (en) | 2010-09-20 | 2012-05-22 | St. Jude Medical, Inc. | Commissure point |
USD653343S1 (en) | 2010-09-20 | 2012-01-31 | St. Jude Medical, Inc. | Surgical cuff |
USD660967S1 (en) * | 2010-09-20 | 2012-05-29 | St. Jude Medical, Inc. | Surgical stent |
USD652926S1 (en) | 2010-09-20 | 2012-01-24 | St. Jude Medical, Inc. | Forked end |
USD648854S1 (en) | 2010-09-20 | 2011-11-15 | St. Jude Medical, Inc. | Commissure points |
USD652927S1 (en) * | 2010-09-20 | 2012-01-24 | St. Jude Medical, Inc. | Surgical stent |
USD653342S1 (en) | 2010-09-20 | 2012-01-31 | St. Jude Medical, Inc. | Stent connections |
USD654170S1 (en) * | 2010-09-20 | 2012-02-14 | St. Jude Medical, Inc. | Stent connections |
USD660433S1 (en) * | 2010-09-20 | 2012-05-22 | St. Jude Medical, Inc. | Surgical stent assembly |
USD654169S1 (en) | 2010-09-20 | 2012-02-14 | St. Jude Medical Inc. | Forked ends |
USD684692S1 (en) | 2010-09-20 | 2013-06-18 | St. Jude Medical, Inc. | Forked ends |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
EP2739214B1 (en) | 2011-08-05 | 2018-10-10 | Cardiovalve Ltd | Percutaneous mitral valve replacement and sealing |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2013033463A1 (en) * | 2011-08-30 | 2013-03-07 | Nitinol Devices And Components, Inc. | Method for manufacturing cylindrical nitinol objects from sheet |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US9913740B2 (en) | 2012-10-25 | 2018-03-13 | W. L. Gore & Associates, Inc. | Stent with varying cross-section |
EP2948103B1 (en) | 2013-01-24 | 2022-12-07 | Cardiovalve Ltd | Ventricularly-anchored prosthetic valves |
CN105163692B (en) | 2013-02-28 | 2017-09-15 | 波士顿科学国际有限公司 | Reduce the implantable medicine equipment of tissue inflammation |
US10583002B2 (en) | 2013-03-11 | 2020-03-10 | Neovasc Tiara Inc. | Prosthetic valve with anti-pivoting mechanism |
CA2903848C (en) | 2013-03-14 | 2022-03-29 | Intersect Ent, Inc. | Systems, devices, and method for treating a sinus condition |
US9681951B2 (en) | 2013-03-14 | 2017-06-20 | Edwards Lifesciences Cardiaq Llc | Prosthesis with outer skirt and anchors |
US9180031B2 (en) | 2013-03-15 | 2015-11-10 | Covidien Lp | Stent with varying radius between struts |
US9259335B2 (en) | 2013-03-15 | 2016-02-16 | Covidien Lp | Stent |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
US20140350657A1 (en) * | 2013-05-21 | 2014-11-27 | Cook Medical Technologies Llc | Expandable medical device with an end structure having a transitional surface |
AU2014284216B2 (en) | 2013-06-21 | 2017-10-05 | Boston Scientific Scimed, Inc. | Stent with deflecting connector |
US9364350B2 (en) | 2013-07-09 | 2016-06-14 | Abbott Cardiovascular Systems Inc. | Stent with eased corner feature |
USD730521S1 (en) | 2013-09-04 | 2015-05-26 | St. Jude Medical, Cardiology Division, Inc. | Stent with commissure attachments |
USD730520S1 (en) | 2013-09-04 | 2015-05-26 | St. Jude Medical, Cardiology Division, Inc. | Stent with commissure attachments |
WO2016016899A1 (en) | 2014-07-30 | 2016-02-04 | Mitraltech Ltd. | Articulatable prosthetic valve |
JP2018027105A (en) * | 2014-12-24 | 2018-02-22 | テルモ株式会社 | Method of manufacturing stent |
EP3247447B1 (en) | 2015-01-22 | 2023-08-23 | Intersect ENT, Inc. | Drug-coated expandable device for treating nasal, otic, or throat conditions |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
ES2978714T3 (en) | 2015-02-05 | 2024-09-18 | Cardiovalve Ltd | Prosthetic valve with axial sliding frames |
US10363130B2 (en) | 2016-02-05 | 2019-07-30 | Edwards Lifesciences Corporation | Devices and systems for docking a heart valve |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
USD802765S1 (en) * | 2016-05-13 | 2017-11-14 | St. Jude Medical, Cardiology Division, Inc. | Surgical stent |
USD802766S1 (en) * | 2016-05-13 | 2017-11-14 | St. Jude Medical, Cardiology Division, Inc. | Surgical stent |
USD802764S1 (en) * | 2016-05-13 | 2017-11-14 | St. Jude Medical, Cardiology Division, Inc. | Surgical stent |
GB201613219D0 (en) | 2016-08-01 | 2016-09-14 | Mitraltech Ltd | Minimally-invasive delivery systems |
CN109789018B (en) | 2016-08-10 | 2022-04-26 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with coaxial frame |
EP3503846B1 (en) | 2016-08-26 | 2021-12-01 | St. Jude Medical, Cardiology Division, Inc. | Prosthetic heart valve with paravalvular leak mitigation features |
US10258488B2 (en) | 2016-11-14 | 2019-04-16 | Covidien Lp | Stent |
US10449069B2 (en) | 2016-11-14 | 2019-10-22 | Covidien Lp | Stent |
US10905572B2 (en) | 2016-11-14 | 2021-02-02 | Covidien Lp | Stent |
USD867595S1 (en) | 2017-02-01 | 2019-11-19 | Edwards Lifesciences Corporation | Stent |
USD889653S1 (en) * | 2017-05-15 | 2020-07-07 | St. Jude Medical, Cardiology Division, Inc. | Stent having tapered struts |
USD875250S1 (en) * | 2017-05-15 | 2020-02-11 | St. Jude Medical, Cardiology Division, Inc. | Stent having tapered aortic struts |
USD875935S1 (en) * | 2017-05-15 | 2020-02-18 | St. Jude Medical, Cardiology Division, Inc. | Stent having tapered struts |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US10537426B2 (en) * | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US12064347B2 (en) | 2017-08-03 | 2024-08-20 | Cardiovalve Ltd. | Prosthetic heart valve |
US11318014B2 (en) | 2017-09-19 | 2022-05-03 | Cardiovalve Ltd. | Prosthetic valve delivery system with multi-planar steering |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
AU2020208468A1 (en) | 2019-01-18 | 2021-08-05 | W. L. Gore & Associates, Inc. | Bioabsorbable medical devices |
US10702407B1 (en) * | 2019-02-28 | 2020-07-07 | Renata Medical, Inc. | Growth stent for congenital narrowings |
WO2024124034A1 (en) | 2022-12-09 | 2024-06-13 | Renata Medical, Inc. | Transcatheter growth devices and methods for norwood, glenn and fontan therapy |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4893623A (en) * | 1986-12-09 | 1990-01-16 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US5035706A (en) * | 1989-10-17 | 1991-07-30 | Cook Incorporated | Percutaneous stent and method for retrieval thereof |
CA2087132A1 (en) | 1992-01-31 | 1993-08-01 | Michael S. Williams | Stent capable of attachment within a body lumen |
DE4303181A1 (en) | 1993-02-04 | 1994-08-11 | Angiomed Ag | Implantable catheter |
US5913897A (en) | 1993-09-16 | 1999-06-22 | Cordis Corporation | Endoprosthesis having multiple bridging junctions and procedure |
EP0657147B1 (en) | 1993-11-04 | 1999-08-04 | C.R. Bard, Inc. | Non-migrating vascular prosthesis |
JP2703510B2 (en) | 1993-12-28 | 1998-01-26 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Expandable stent and method of manufacturing the same |
US5843120A (en) | 1994-03-17 | 1998-12-01 | Medinol Ltd. | Flexible-expandable stent |
US5397355A (en) | 1994-07-19 | 1995-03-14 | Stentco, Inc. | Intraluminal stent |
AU3783195A (en) | 1994-11-15 | 1996-05-23 | Advanced Cardiovascular Systems Inc. | Intraluminal stent for attaching a graft |
CA2301351C (en) | 1994-11-28 | 2002-01-22 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for direct laser cutting of metal stents |
US5591197A (en) | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
CA2171896C (en) | 1995-03-17 | 2007-05-15 | Scott C. Anderson | Multi-anchor stent |
US5746766A (en) * | 1995-05-09 | 1998-05-05 | Edoga; John K. | Surgical stent |
US5769882A (en) | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
US5824036A (en) | 1995-09-29 | 1998-10-20 | Datascope Corp | Stent for intraluminal grafts and device and methods for delivering and assembling same |
US5593417A (en) | 1995-11-27 | 1997-01-14 | Rhodes; Valentine J. | Intravascular stent with secure mounting means |
US6203569B1 (en) * | 1996-01-04 | 2001-03-20 | Bandula Wijay | Flexible stent |
DK0955950T3 (en) * | 1996-01-04 | 2006-07-31 | Timothy A M Dr Chuter | Flat Wire Stent |
JP2001502605A (en) * | 1996-01-30 | 2001-02-27 | メドトロニック,インコーポレーテッド | Articles and methods for making a stent |
US5843117A (en) | 1996-02-14 | 1998-12-01 | Inflow Dynamics Inc. | Implantable vascular and endoluminal stents and process of fabricating the same |
AR001162A1 (en) | 1996-03-06 | 1997-09-24 | Parodi Juan C | Non-migratory positioning endovascular expander |
EP0795304B1 (en) | 1996-03-10 | 2004-05-19 | Terumo Kabushiki Kaisha | Implanting stent |
US5855802A (en) | 1996-05-30 | 1999-01-05 | International Business Machines Corporation | Method and apparatus for forming a tubular article having a perforated annular wall |
US5911752A (en) | 1996-09-13 | 1999-06-15 | Intratherapeutics, Inc. | Method for collapsing a stent |
US5755778A (en) | 1996-10-16 | 1998-05-26 | Nitinol Medical Technologies, Inc. | Anastomosis device |
US5824053A (en) | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Helical mesh endoprosthesis and methods of use |
US5824054A (en) | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Coiled sheet graft stent and methods of making and use |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US5911754A (en) | 1998-07-24 | 1999-06-15 | Uni-Cath Inc. | Flexible stent with effective strut and connector patterns |
US6355057B1 (en) * | 1999-01-14 | 2002-03-12 | Medtronic, Inc. | Staggered endoluminal stent |
-
2001
- 2001-04-17 US US09/837,353 patent/US20020049490A1/en not_active Abandoned
-
2002
- 2002-03-04 US US10/090,473 patent/US6942690B1/en not_active Expired - Fee Related
-
2005
- 2005-04-20 US US11/110,999 patent/US7740653B1/en not_active Expired - Fee Related
-
2010
- 2010-06-18 US US12/818,950 patent/US8382816B2/en not_active Expired - Fee Related
Cited By (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8801769B2 (en) | 1998-02-09 | 2014-08-12 | Trivascular, Inc. | Endovascular graft |
US8361136B2 (en) | 1998-02-09 | 2013-01-29 | Trivascular, Inc. | Endovascular graft |
US9867727B2 (en) | 1998-02-09 | 2018-01-16 | Trivascular, Inc. | Endovascular graft |
US10548750B2 (en) | 1998-02-09 | 2020-02-04 | Trivascular, Inc. | Endovascular graft |
US9034029B2 (en) * | 1998-03-27 | 2015-05-19 | Covidien Lp | Stents with tapered struts |
US20100228338A1 (en) * | 1998-03-27 | 2010-09-09 | Ev3 Inc. | Stents with tapered struts |
US7766954B2 (en) | 2001-12-20 | 2010-08-03 | Trivascular2, Inc. | Advanced endovascular graft |
US20030120338A1 (en) * | 2001-12-20 | 2003-06-26 | Chobotov Michael V. | Advanced endovascular graft |
US7637935B2 (en) | 2002-05-06 | 2009-12-29 | Abbott Laboratories | Endoprosthesis for controlled contraction and expansion |
US20100063581A1 (en) * | 2002-05-06 | 2010-03-11 | Jeff Pappas | Endoprosthesis For Controlled Contraction And Expansion |
US20040093072A1 (en) * | 2002-05-06 | 2004-05-13 | Jeff Pappas | Endoprosthesis for controlled contraction and expansion |
US8075610B2 (en) | 2002-05-06 | 2011-12-13 | Abbott Laboratories | Endoprosthesis for controlled contraction and expansion |
US20060142844A1 (en) * | 2002-05-08 | 2006-06-29 | David Lowe | Endoprosthesis having foot extensions |
US20040093073A1 (en) * | 2002-05-08 | 2004-05-13 | David Lowe | Endoprosthesis having foot extensions |
US7128756B2 (en) | 2002-05-08 | 2006-10-31 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7985249B2 (en) | 2002-05-08 | 2011-07-26 | Abbott Laboratories Corporation | Endoprosthesis having foot extensions |
US20080262601A1 (en) * | 2002-09-13 | 2008-10-23 | Cully Edward H | Stent Device with Multiple Helix Construction |
US8147538B2 (en) | 2003-03-11 | 2012-04-03 | Boston Scientific Scimed, Inc. | Covered stent |
EP2311405A1 (en) | 2003-03-11 | 2011-04-20 | Boston Scientific Limited | Covered stent |
US20080114447A1 (en) * | 2003-03-11 | 2008-05-15 | Boston Scientific Scimed, Inc. | Covered stent |
US7771463B2 (en) | 2003-03-26 | 2010-08-10 | Ton Dai T | Twist-down implant delivery technologies |
US20040193178A1 (en) * | 2003-03-26 | 2004-09-30 | Cardiomind, Inc. | Multiple joint implant delivery systems for sequentially-controlled implant deployment |
US7785361B2 (en) | 2003-03-26 | 2010-08-31 | Julian Nikolchev | Implant delivery technologies |
US8016869B2 (en) | 2003-03-26 | 2011-09-13 | Biosensors International Group, Ltd. | Guidewire-less stent delivery methods |
US20070043419A1 (en) * | 2003-03-26 | 2007-02-22 | Cardiomind, Inc. | Implant delivery technologies |
US20060015173A1 (en) * | 2003-05-06 | 2006-01-19 | Anton Clifford | Endoprosthesis having foot extensions |
US20070021834A1 (en) * | 2003-05-06 | 2007-01-25 | Eugene Young | Endoprosthesis having foot extensions |
US8915954B2 (en) | 2003-05-06 | 2014-12-23 | Abbott Laboratories | Endoprosthesis having foot extensions |
US20050107865A1 (en) * | 2003-05-06 | 2005-05-19 | Anton Clifford | Endoprosthesis having foot extensions |
US8048146B2 (en) | 2003-05-06 | 2011-11-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US20100049304A1 (en) * | 2003-05-06 | 2010-02-25 | Abbott Laboratories | Endoprosthesis Having Foot Extensions |
US8109991B2 (en) | 2003-05-06 | 2012-02-07 | Abbot Laboratories | Endoprosthesis having foot extensions |
US7803178B2 (en) | 2004-01-30 | 2010-09-28 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
US8267989B2 (en) | 2004-01-30 | 2012-09-18 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
US20050209675A1 (en) * | 2004-03-02 | 2005-09-22 | Ton Dai T | Corewire actuated delivery system with fixed distal stent-carrying extension |
US7651521B2 (en) | 2004-03-02 | 2010-01-26 | Cardiomind, Inc. | Corewire actuated delivery system with fixed distal stent-carrying extension |
US20050228484A1 (en) * | 2004-03-11 | 2005-10-13 | Trivascular, Inc. | Modular endovascular graft |
EP1753368A2 (en) * | 2004-06-08 | 2007-02-21 | Medinol Ltd. | Stent having struts with reverse direction curvature |
EP1753368A4 (en) * | 2004-06-08 | 2008-05-14 | Medinol Ltd | Stent having struts with reverse direction curvature |
JP2008501461A (en) * | 2004-06-08 | 2008-01-24 | メディノール リミティド | Stent with struts having opposite curvature |
US20050273157A1 (en) * | 2004-06-08 | 2005-12-08 | Gregory Pinchasik | Stent having struts with reverse direction curvature |
US7763064B2 (en) | 2004-06-08 | 2010-07-27 | Medinol, Ltd. | Stent having struts with reverse direction curvature |
WO2005120394A2 (en) | 2004-06-08 | 2005-12-22 | Medinol, Ltd. | Stent having struts with reverse direction curvature |
AU2005251525B2 (en) * | 2004-06-08 | 2009-05-21 | Medinol, Ltd. | Stent having struts with reverse direction curvature |
WO2006044147A2 (en) * | 2004-10-14 | 2006-04-27 | Cardiomind, Inc. | Small vessel stent designs |
JP2008516668A (en) * | 2004-10-14 | 2008-05-22 | カーディオマインド, インコーポレイテッド | Small tube stent design |
WO2006044147A3 (en) * | 2004-10-14 | 2007-12-27 | Cardiomind Inc | Small vessel stent designs |
US20060136037A1 (en) * | 2004-10-14 | 2006-06-22 | Debeer Nicholas C | Small vessel stent designs |
AU2005313947B2 (en) * | 2004-12-09 | 2010-09-23 | Cook Medical Technologies Llc | Variable curvature stent |
US20060161243A1 (en) * | 2004-12-09 | 2006-07-20 | Cook Group Patent Office | S-shaped stent design |
US7655033B2 (en) * | 2004-12-09 | 2010-02-02 | Med Institute, Inc. | S-shaped stent design |
US7473272B2 (en) * | 2005-08-17 | 2009-01-06 | Medtronic Vascular, Inc. | Recapturable stent with minimum crossing profile |
US20070043424A1 (en) * | 2005-08-17 | 2007-02-22 | Medtronic Vascular, Inc. | Recapturable stent with minimum crossing profile |
US20070073379A1 (en) * | 2005-09-29 | 2007-03-29 | Chang Jean C | Stent delivery system |
US7862602B2 (en) | 2005-11-02 | 2011-01-04 | Biosensors International Group, Ltd | Indirect-release electrolytic implant delivery systems |
US8900285B2 (en) | 2005-11-02 | 2014-12-02 | Biosensors International Group, Ltd. | Covering electrolytic restraint implant delivery systems |
US8273116B2 (en) | 2005-11-02 | 2012-09-25 | Biosensors International Group, Ltd. | Indirect-release electrolytic implant delivery systems |
US8579954B2 (en) | 2005-11-02 | 2013-11-12 | Biosensors International Group, Ltd. | Untwisting restraint implant delivery system |
US8974509B2 (en) | 2005-11-02 | 2015-03-10 | Biosensors International Group, Ltd. | Pass-through restraint electrolytic implant delivery systems |
US20070185560A1 (en) * | 2005-11-28 | 2007-08-09 | Cook Incorporated | Expandable stent |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
US12016766B2 (en) | 2007-10-04 | 2024-06-25 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
US10159557B2 (en) | 2007-10-04 | 2018-12-25 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
US10682222B2 (en) | 2007-10-04 | 2020-06-16 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
CN101969883A (en) * | 2007-12-26 | 2011-02-09 | 梅德学会公司 | Stent and method of making a stent |
WO2009085190A1 (en) * | 2007-12-26 | 2009-07-09 | Med Institute, Inc. | Stent and method of making a stent |
US20090248134A1 (en) * | 2007-12-26 | 2009-10-01 | Med Institute, Inc. | Stent with polished eyelet |
AU2008343845B2 (en) * | 2007-12-26 | 2013-02-21 | Cook Medical Technologies Llc | Stent and method of making a stent |
US8657870B2 (en) | 2009-06-26 | 2014-02-25 | Biosensors International Group, Ltd. | Implant delivery apparatus and methods with electrolytic release |
US20110009941A1 (en) * | 2009-07-08 | 2011-01-13 | Concentric Medical, Inc. | Vascular and bodily duct treatment devices and methods |
EP2833830A4 (en) * | 2012-04-04 | 2015-12-09 | Trivascular Inc | Durable stent graft with tapered struts and stable delivery methods and devices |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
WO2014081564A3 (en) * | 2012-11-20 | 2014-07-17 | Medtronic Inc. | Valve prosthesis frames |
JP5586742B1 (en) * | 2013-06-28 | 2014-09-10 | 株式会社World Medish | High flexibility stent |
JP2015008931A (en) * | 2013-06-28 | 2015-01-19 | 株式会社World Medish | Highly-flexible stent |
JP5550028B1 (en) * | 2014-01-27 | 2014-07-16 | 株式会社World Medish | High flexibility stent |
JP2015009143A (en) * | 2014-01-27 | 2015-01-19 | 株式会社World Medish | Highly-flexible stent |
KR20190109752A (en) * | 2017-02-02 | 2019-09-26 | 씨. 알. 바드, 인크. | Short stent |
US10905578B2 (en) * | 2017-02-02 | 2021-02-02 | C. R. Bard, Inc. | Short stent |
US20210161693A1 (en) * | 2017-02-02 | 2021-06-03 | C. R. Bard, Inc. | Short Stent |
KR102331203B1 (en) | 2017-02-02 | 2021-11-24 | 씨. 알. 바드, 인크. | SHORT STENT |
EP3576671A4 (en) * | 2017-02-02 | 2021-01-20 | C.R. Bard, Inc. | SHORT STENT |
US12090073B2 (en) * | 2017-02-02 | 2024-09-17 | C. R. Bard, Inc. | Short stent |
EP4212133A4 (en) * | 2020-09-11 | 2024-09-25 | JMR Co., Ltd. | STENT AND METHOD FOR PRODUCING STENT |
CN113229995A (en) * | 2021-04-08 | 2021-08-10 | 温州医科大学附属第二医院(温州医科大学附属育英儿童医院) | Self-expanding intrabody absorption biliary tract stent |
CN118267208A (en) * | 2024-04-11 | 2024-07-02 | 重庆医科大学附属第一医院 | Peripheral arterial support |
Also Published As
Publication number | Publication date |
---|---|
US8382816B2 (en) | 2013-02-26 |
US6942690B1 (en) | 2005-09-13 |
US20100256737A1 (en) | 2010-10-07 |
US7740653B1 (en) | 2010-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020049490A1 (en) | Single-piece endoprosthesis with high expansion ratios | |
US5843164A (en) | Intraluminal stent for attaching a graft | |
US5800526A (en) | Multi-anchor stent | |
EP1307162B1 (en) | Endovascular graft system | |
JP7075660B2 (en) | Stent | |
EP1035810B1 (en) | Endovascular graft system | |
ES2222197T3 (en) | ENDOVASCULAR PROTESIS OF ROLLED SHEET, WHICH INCLUDES A SLIDING EXOSKELET. | |
US6699277B1 (en) | Stent with cover connectors | |
EP1522277B1 (en) | Stent-Graft with slidably mounted graft material and method of attachment | |
JP4825665B2 (en) | Lumen device with enhanced mounting characteristics | |
US20040215329A1 (en) | Stent with cover connectors | |
JPH0852165A (en) | Device and method for arrangement of transplanting piece in cavity | |
CN115697255A (en) | Inflatable instruments and related systems and methods | |
US20090149945A1 (en) | Prosthetic support for flaccid arterial segments | |
EP0799607A2 (en) | Intravascular stent having flattened profile | |
AU701676B2 (en) | Intraluminal stent for attaching a graft |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ENDOVASCULAR TECHNOLOGIES, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:POLLOCK, DAVID T.;ESCANO, ARNOLD M.;REEL/FRAME:011733/0366;SIGNING DATES FROM 20010406 TO 20010409 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |